I dont see any big deal about this.
Their market model is b2b and mostly medical device suppliers/manuafacturers.
I am not suprise they will hire someone who has strong experience in this field or marketing related .
In addition, they said in previous announcement that they want to save around 100k per quarter so cutting costs to focus on their development activities is a good thing for shareholders.
Have you seen a company that generate revenue around 200-300k plus per quarter, burning costs around 800k or less with a market cap around $10-$11m. No CR is required for a long tkme so hopefully they will break even in the soon future.
I am keen to see if the top 20 holders remain the same.
Trading activities have been very low so I am happy to keep this company long term.
They serious need to do more roadshows and start talking with the brokers to gain their support.
- Forums
- ASX - By Stock
- Ann: Director Appointment / Resignation
I dont see any big deal about this. Their market model is b2b...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IRX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.591M |
Open | High | Low | Value | Volume |
3.5¢ | 4.0¢ | 3.5¢ | $3.865K | 100.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 17000 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 108387 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 17000 | 0.030 |
1 | 12000 | 0.028 |
1 | 500000 | 0.020 |
1 | 100099 | 0.010 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 108387 | 2 |
0.050 | 250000 | 1 |
0.054 | 244870 | 1 |
0.060 | 200000 | 1 |
0.070 | 18999 | 1 |
Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
Last
3.9¢ |
  |
Change
0.000 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
3.9¢ | 3.9¢ | 3.9¢ | 5714 | ||
Last updated 13.13pm 17/05/2024 ? |
Featured News
IRX (ASX) Chart |